Download
s13346-020-00888-0.pdf 5,74MB
WeightNameValue
1000 Titel
  • Investigating hesperetin nanocrystals with tailor-made sizes for the prevention and treatment of Alzheimer’s disease
1000 Autor/in
  1. Stahr, Pascal-L. |
  2. Grewal, Rekha |
  3. Eckert, Gunter P. |
  4. Keck, Cornelia M. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-01-12
1000 Erschienen in
1000 Quellenangabe
  • 11(2):659-674
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s13346-020-00888-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987607/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Poor aqueous solubility of drug substances is associated with poor bioavailability and thus hampers the effective use of many potent active pharmaceutical ingredients. Various strategies to overcome poor solubility are available, whereby drug nanocrystals represent one of the most powerful formulation strategies to enhance the kinetic solubility and dissolution rate of poorly soluble drugs. Nanocrystals are simply obtained by milling large-sized drug powders to sizes < 1 µm. The so obtained nanocrystals possess an increased dissolution rate and kinetic solubility when compared with larger-sized bulk material. The aim of this study was to produce differently sized hesperetin nanocrystals and to investigate the influence of nanocrystal size on the bioefficacy of the natural antioxidant hesperetin in two cell culture models for the prevention and treatment of Alzheimer's disease. Results showed that the testing of poorly soluble compounds is challenging and requires incredibly careful characterization. Reasons for this are possible changes of the formulations in cell culture media which can occur due to various reasons. If the changes are not considered, results obtained can be misleading and even lead to a false interpretation of the results obtained. Besides, results demonstrate the increase in dissolution rate with decreasing particle size that is especially pronounced with particle sizes < 200 nm. Data also provide clear evidence that smaller nanocrystals with higher kinetic solubility possess higher antioxidant capacity. This results in lower amounts of free radicals in the cell culture models, suggesting that hesperetin nanocrystals, that improve the poor aqueous solubility of hesperetin, are promising for the prevention and treatment of Alzheimer's disease.
1000 Sacherschließung
lokal Alzheimer’s disease
lokal Zeta potential
lokal Humans [MeSH]
lokal Alzheimer Disease/drug therapy [MeSH]
lokal Hesperidin [MeSH]
lokal Antioxidant
lokal Alzheimer Disease/prevention
lokal Hesperetin
lokal Solubility [MeSH]
lokal Research Article
lokal Nanocrystals
lokal Nanoparticles [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3RhaHIsIFBhc2NhbC1MLg==|https://frl.publisso.de/adhoc/uri/R3Jld2FsLCBSZWtoYQ==|https://frl.publisso.de/adhoc/uri/RWNrZXJ0LCBHdW50ZXIgUC4=|https://frl.publisso.de/adhoc/uri/S2VjaywgQ29ybmVsaWEgTS4=
1000 Hinweis
  • DeepGreen-ID: f601afa096fd427881065eb94102033f ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6444118.rdf
1000 Erstellt am 2023-04-27T12:03:32.628+0200
1000 Erstellt von 322
1000 beschreibt frl:6444118
1000 Zuletzt bearbeitet Fri Oct 20 12:02:06 CEST 2023
1000 Objekt bearb. Fri Oct 20 12:02:06 CEST 2023
1000 Vgl. frl:6444118
1000 Oai Id
  1. oai:frl.publisso.de:frl:6444118 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source